Hospital
West Carroll Health Systems LLC
West Carroll Health Systems LLC was paid $6.08M by Medicaid between Jan 2018 and Dec 2024, across 73 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 43% of everything it billed.
33Billing provider infoWEST CARROLL HEALTH SYSTEMS LLC
OAK GROVE, LA 71263
OAK GROVE, LA 71263
33aNPI1306843826assigned 06/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.08M
24GClaims191,595
24DCodes billed73
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#44 of 96
Median peer was paid$5.17M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,467 | $367K | |
| 2019 | 25,672 | $507K | |
| 2020 | 19,910 | $460K | |
| 2021 | 26,456 | $1.01M | |
| 2022 | 31,085 | $1.32M | |
| 2023 | 35,382 | $1.57M | |
| 2024incomplete | 31,623 | $857K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 43% | 9,142 | 7,299 | $2.62M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 19% | 14,276 | 11,340 | $1.13M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.6% | 2,911 | 2,181 | $342K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.4% | 774 | 662 | $269K |
| 71045 | Radiologic examination, chest; single view | 2.8% | 2,075 | 1,667 | $170K |
| 80053 | Comprehensive metabolic panel | 2.7% | 22,623 | 18,780 | $165K |
| 71046 | Radiologic examination, chest; 2 views | 2.3% | 2,806 | 2,303 | $140K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 27,006 | 21,005 | $139K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 2,122 | 1,528 | $108K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 1,277 | 988 | $99K |
| 80305 | 1.5% | 7,867 | 5,921 | $92K | |
| 80061 | Lipid panel | 1.5% | 8,280 | 7,577 | $90K |
61 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 6,849 | $90K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 36,160 | $72K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 249 | $70K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,447 | $33K |
| 84439 | <1% | 4,114 | $30K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,394 | $30K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,229 | $28K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 342 | $25K |
| 93041 | <1% | 368 | $24K | |
| 87486 | <1% | 760 | $23K | |
| 87581 | <1% | 759 | $23K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 757 | $23K |
| 80076 | <1% | 2,822 | $21K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 447 | $20K |
| 74018 | <1% | 234 | $18K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 30 | $18K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,532 | $16K |
| 84703 | <1% | 2,238 | $14K | |
| 83880 | <1% | 769 | $13K | |
| 82652 | <1% | 861 | $11K | |
| 81001 | <1% | 6,889 | $11K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 591 | $10K |
| 83735 | <1% | 2,215 | $8K | |
| 84484 | <1% | 1,320 | $8K | |
| 82553 | <1% | 1,404 | $6K | |
| 74019 | <1% | 74 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 248 | $6K |
| 11056 | <1% | 240 | $5K | |
| 82550 | <1% | 1,376 | $5K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 76 | $5K |
| 83615 | <1% | 1,330 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 145 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 317 | $4K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 217 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 116 | $3K |
| 94760 | <1% | 372 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 68 | $2K |
| 11720 | <1% | 344 | $2K | |
| 87276 | <1% | 236 | $2K | |
| 87275 | <1% | 236 | $2K | |
| 83690 | <1% | 463 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 51 | $2K |
| 82150 | <1% | 463 | $2K | |
| 82728 | <1% | 143 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15 | $994.93 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $947.34 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 67 | $928.57 |
| 83540 | <1% | 179 | $698.01 | |
| 83550 | <1% | 132 | $669.06 | |
| 82607 | <1% | 64 | $596.44 | |
| 85379 | <1% | 80 | $509.00 | |
| 82746 | <1% | 35 | $271.96 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 43 | $220.48 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 20 | $177.58 |
| E0325 | Urinal; male, jug-type, any material | <1% | 38 | $169.20 |
| 86140 | <1% | 40 | $155.40 | |
| 82043 | <1% | 66 | $83.30 | |
| 82570 | <1% | 66 | $74.65 | |
| 85007 | <1% | 33 | $13.64 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 196 | $0.00 |
| A6219 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORRIS, RAYMOND (OWNER ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| West Carroll Health Systems LLC | Oak Grove, LA | $352K |
| West Carroll Health Systems LLC | Oak Grove, LA | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.